Dadigatran Etexilate Mesylate Capsules 110mg.......

Dadigatran Etexilate Mesylate Capsules 110mg
DABIGATREX 110  is an anticoagulant medication commonly prescribed to reduce the risk of stroke and systemic embolism in individuals with non-valvular atrial fibrillation.DABIGATREX 110 belongs to a class of drugs known as direct thrombin inhibitors. 
DABIGATREX 110  is a prodrug that is converted to its active form, dabigatran, in the body.DABIGATREX 110  directly inhibits thrombin, a key enzyme in the blood coagulation process, preventing the formation of blood clots.

DABIGATREX 110  is administered orally in the form of capsules.
DABIGATREX 110 is usually taken with a full glass of water, and the capsules should be swallowed whole. Breaking or opening the capsules can interfere with the drug's proper release.

DABIGATREX 110   is primarily used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
DABIGATREX 110 may also be prescribed for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Unlike some older anticoagulants like warfarin, routine monitoring of blood clotting parameters (INR) is not required with dabigatran. However, renal function should be assessed periodically.
Common side effects may include gastrointestinal symptoms such as dyspepsia (indigestion) and gastritis.
Serious side effects may include bleeding. Patients should seek medical attention DABIGATREX 110   they experience signs of severe bleeding, such as unusual bruising, prolonged bleeding, or blood in urine or stool.
Contraindications:
DABIGATREX 110  is contraindicated in individuals with a history of hypersensitivity to the drug and those with active pathological bleeding.
Precautions:
DABIGATREX 110   is advised in patients with conditions that may increase the risk of bleeding, such as renal impairment.
DABIGATREX 110  important to inform healthcare providers about all medications, including over-the-counter drugs and supplements, to avoid potential interactions.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:https://www.sterisonline.com/product/dabigatrex-110-133287